|
Market Closed -
Xetra
12:35:30 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 4.680 EUR | -0.43% |
|
-2.50% | -19.31% |
| 09-17 | Novo, Orbis sign up to $1.4 billion deal to develop oral drugs | RE |
| 08-19 | ORBIS AG Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Chart: Technical Analysis
XetraEUR
| Markets | Quality | ||
|---|---|---|---|
Xetra
| OBS | Delayed | |
Deutsche Boerse AG
| OBS | Delayed | |
|
Tradegate
| OBS | Real-time | |
|
Börse Stuttgart
| OBS | Delayed | |
|
Boerse Muenchen
| OBS | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 4.8 | 4.94 | 5.25 |
| Spread/Res. | -2.50% | -5.26% | -10.86% |
| Spread/Supp. | +1.74% | +3.08% | +2.63% |
| Support | 4.6 | 4.54 | 4.56 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- OBS Stock
- Charts ORBIS AG
Select your edition
All financial news and data tailored to specific country editions
